Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Not yet recruiting
- Conditions
- Chondrosarcoma
- Registration Number
- NCT06029478
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.
This study will admit a wide range of data on the clinical trial experience of chondrosarcoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chondrosarcoma patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Aged ≥ 18 years old
- Able to comprehend the investigational nature of the protocol and provide informed consent
- Diagnosis of chondrosarcoma
Exclusion Criteria
- No diagnosis of chondrosarcoma confirmed
- Inability to perform regular electronic reporting
- Patient does not understand, sign, and return consent form
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of chondrosarcoma patients who decide to enroll in a clinical trial 3 months Rate of chondrosarcoma patients who remain in clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States